Dr. Rakesh Prashad, MD

Dr. Prashad practices at Citrus Cardiology Consultants in Ocala, Florida.

Dr. Prashad's NPI, 1992800155, was assigned on September 13, 2006. Dr. Prashad graduated from University Of Florida College Of Medicine in 1989. Dr. Prashad holds Florida license ME58762.

Dr. Prashad's primary practice is Citrus Cardiology Consultants, at 2101 Sw 20th Pl, Ocala, FL 34471-7734. The practice phone is (352) 622-7008.

Dr. Prashad's primary practice is Citrus Cardiology Consultants in Ocala, Florida. Dr. Prashad is also affiliated with HCA Florida Ocala Hospital. The medical group on file is Citrus Cardiology Consultants. Dmand AI also links Dr. Prashad to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prashad practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Prashad's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Prashad is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Prashad is licensed in Florida.

Dmand AI lists angioplasty, cardiac catheterization, pacemaker or defibrillator implantation, pacemaker replacement and varicose vein treatment among the conditions Dr. Prashad treats.

CMS data shows 12,321 Medicare services from Dr. Prashad across 52 procedure codes in 2024, for 1,317 Medicare patients. Medicare paid $707,409 for them.

CMS counts 1,317 Medicare patients who saw Dr. Prashad in 2024. The largest group is 75 to 84, with 602 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Prashad's median patient age at 76, with 48% women.

In 2024, Dr. Prashad wrote 6,996 Medicare Part D claims for 953 patients. 85% of them were for generic drugs. CMS names the drug for 6,757 of them, across 54 drugs with 11 or more claims each, at $1,242,703 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Prashad for performance year 2024, reported individually. Dr. Prashad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of pacemaker insertion or repair by Dr. Prashad, more than 62% of the clinicians it reports for that procedure.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Prashad, published from 2011 to 2023. 2022 was the busiest year, with 4. The most frequent topics are Cardiovascular Diseases, Chelating Agents and Chelation Therapy. Dr. Prashad has published most often in Cardiol Res. Dr. Prashad's most frequent co-authors are Gervasio A. Lamas, MD, Francisco Ujueta, MD and Yamil Wady Aude, MD.

Dmand AI links Dr. Prashad to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Diabetes Mellitus, Type 2, Ischemia and Coronary Artery Disease.

CMS Open Payments shows 111 general payments to Dr. Prashad from 27 drug and device companies from 2024 to 2025. Travel and lodging make up the largest share, 57% of the total. Boston Scientific Corporation paid the most, $4,532.

Dr. Prashad graduated from University Of Florida College Of Medicine in 1989.

Dr. Prashad is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.